Cargando…

Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar

Myeloproliferative neoplasms are a diversified group of diseases of the hematopoietic stem cell, such as essential thrombocythemia (ET) and polycythemia vera. They are mainly caused by mutations in the following genes: JAK2, CALR, and MPL. All carry an increased risk to transform into acute leukemia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu-Tineh, Mohammad, Kassem, Nancy, Abdulla, Mohammad Abdul-Jaber, Ismail, Omar Mohammad, Ghasoub, Rola, Aldapt, Mahmood B., Yassin, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154247/ https://www.ncbi.nlm.nih.gov/pubmed/32308601 http://dx.doi.org/10.1159/000506447

Ejemplares similares

Outcome of Pregnancy in the Era of PEGylated Interferon-α2a in Females with Chronic Myeloid Leukemia: An Experience from Qatar
por: Abu-Tineh, Mohammad, et al.
Publicado: (2020)

Extreme Levels of Platelet Count in Essential Thrombocythemia: Management and Outcome, Report of Two Cases
por: Abu-Tineh, Mohammad, et al.
Publicado: (2020)

Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report
por: Elhassan, Afra M., et al.
Publicado: (2020)

Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2)
por: Afana, Mohammad, et al.
Publicado: (2023)

Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project
por: Yassin, Mohamed A., et al.
Publicado: (2021)

Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: A protocol for systematic review and meta-analysis
por: Kassem, Nancy, et al.
Publicado: (2020)

Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment
por: Aldapt, Mahmood B., et al.
Publicado: (2018)

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World
por: Sun, Yingxin, et al.
Publicado: (2021)

Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report
por: Altayyan, Mahmoud M, et al.
Publicado: (2023)

Congenital Methemoglobinemia: First Confirmed Case in the Arab Population with a Novel Variant in the CYB5R Gene in the State of Qatar: A Case Report
por: Al-Abdulmalek, Abdulrahman, et al.
Publicado: (2023)

The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience
por: Yassin, Mohamed A, et al.
Publicado: (2022)

Hematological indices reference intervals for a healthy Arab population in Qatar: Effect of age, gender, and geographic location
por: Yassin, Mohamed A., et al.
Publicado: (2022)

Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
por: Al-Dubai, Husam N., et al.
Publicado: (2020)

Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2(V617F) allelic burden
por: Kovacsovics-Bankowski, Magdalena, et al.
Publicado: (2016)

Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
por: Ismail, Omar M., et al.
Publicado: (2021)

A Case of Chronic Neutrophilic Leukemia Successfully Treated with Pegylated Interferon Alpha-2a
por: Yassin, Mohamed A, et al.
Publicado: (2015)

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
por: Masarova, Lucia, et al.
Publicado: (2017)

Chronic Myeloid Leukemia Preceded by Tuberculosis
por: Al-Qudah, Bara M., et al.
Publicado: (2020)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report
por: Abu-Tineh, Mohammad, et al.
Publicado: (2020)

Interferon alpha therapy in essential thrombocythemia and polycythemia vera - a systematic review and meta-analysis
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2020)

Challenges facing teacher education in Qatar: Q methodology research
por: Alkhateeb, Hadeel, et al.
Publicado: (2022)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
por: Abu-Tineh, Mohammad, et al.
Publicado: (2021)

Sickle cell leg ulcer successfully managed by hyperbaric oxygen: a case report
por: Alshurafa, Awni, et al.
Publicado: (2023)

Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects
por: ALBRECHT, Jana D., et al.
Publicado: (2022)

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
por: Mascarenhas, J, et al.
Publicado: (2019)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
por: Nuruddin, Murtuza, et al.
Publicado: (2022)

Efficacy and safety of pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV): results of a phase 2 study after a 7-year median follow-up
por: Masarova, Lucia, et al.
Publicado: (2017)

Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis
por: Adel, Ahmad, et al.
Publicado: (2021)

Leukemia Cutis as an Early Presentation or Relapsing Manifestation of Chronic Lymphocytic Leukemia (CLL)
por: Aldapt, Mahmood B, et al.
Publicado: (2021)

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
por: Al-Dewik, Nader I., et al.
Publicado: (2016)

Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
por: Kashif, Muhammad, et al.
Publicado: (2015)

Subcutaneous Masses as an Unusual Manifestation of Relapse in a Case of Atypical Chronic Lymphocytic Leukemia with Prolymphocytoid Transformation and Complex Karyotype: A Diagnostic Dilemma and Treatment Challenge
por: Aldapt, Mahmood B., et al.
Publicado: (2020)

Nanomedicines in the treatment of chronic hepatitis C – focus on pegylated interferon alpha-2a
por: Thomas, Thea, et al.
Publicado: (2007)

Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy for essential thrombocythemia: a case report
por: Qin, Chunmei, et al.
Publicado: (2023)

Invasive ductal breast carcinoma preceded by CALR‐positive essential thrombocythemia
por: Ali, Elrazi A., et al.
Publicado: (2021)

Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
por: Stegelmann, Frank, et al.
Publicado: (2023)

Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): A cross-sectional study
por: Alshurafa, Awni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i7dq1tcvjgggk2s7mele9325qe